Operating Lease, Right-of-Use Asset of ASSEMBLY BIOSCIENCES, INC. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ASSEMBLY BIOSCIENCES, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • ASSEMBLY BIOSCIENCES, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $2,644,000, a 86% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ASSEMBLY BIOSCIENCES, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,644,000 +$1,223,000 +86% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $2,782,000 +$1,051,000 +61% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $2,927,000 +$891,000 +44% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $3,069,000 +$730,000 +31% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $1,421,000 +$577,000 +68% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $1,731,000 +$108,000 +6.7% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $2,036,000 -$383,000 -16% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $2,339,000 -$856,000 -27% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $844,000 -$3,114,000 -79% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $1,623,000 -$3,088,000 -66% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $2,419,000 -$2,881,000 -54% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $3,195,000 -$2,847,000 -47% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $3,958,000 -$2,815,000 -42% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $4,711,000 -$2,777,000 -37% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $5,300,000 -$2,804,000 -35% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $6,042,000 -$3,089,000 -34% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $6,773,000 -$3,624,000 -35% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $7,488,000 -$3,292,000 -31% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $8,104,000 -$3,375,000 -29% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $9,131,000 -$2,844,000 -24% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 $10,397,000 -$2,386,000 -19% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $10,780,000 -$1,892,000 -15% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $11,479,000 -$1,584,000 -12% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $11,975,000 +$11,975,000 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $12,783,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $12,672,000 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $13,063,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 04 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.